铂-话题@MedSci

#铂#

382篇内容 | 6034人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1737495, encodeId=a6471e3749502, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=ESMO 2016：卡铂+培美曲塞+派姆单抗，可改善NSCLC患者的PFS, objectType=article, longId=79863, objectId=3fa9e98630a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3fa9e98630a, replyNumber=0, likeNumber=77, createdTime=2016-12-14, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3fa9e98630a, moduleTitle=ESMO 2016：卡铂+培美曲塞+派姆单抗，可改善NSCLC患者的PFS, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3fa9e98630a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737484, encodeId=6cee1e3748479, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Support Care Cancer：文拉法辛可减轻紫杉醇-奥沙利铂引发的急性神经毒性, objectType=article, longId=61412, objectId=8d5461412e8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8d5461412e8, replyNumber=0, likeNumber=59, createdTime=2016-01-18, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8d5461412e8, moduleTitle=Support Care Cancer：文拉法辛可减轻紫杉醇-奥沙利铂引发的急性神经毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8d5461412e8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737487, encodeId=583b1e37487f7, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=NEJM：Veliparib-卡铂治疗三阴性乳腺癌效果好, objectType=article, longId=72400, objectId=4e9ce240078, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e9ce240078, replyNumber=0, likeNumber=68, createdTime=2016-07-27, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e9ce240078, moduleTitle=NEJM：Veliparib-卡铂治疗三阴性乳腺癌效果好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e9ce240078)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737488, encodeId=206d1e37488a3, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=JCO：顺铂的耳毒性研究, objectType=article, longId=72704, objectId=d75fe270480, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d75fe270480, replyNumber=0, likeNumber=67, createdTime=2017-06-18, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d75fe270480, moduleTitle=JCO：顺铂的耳毒性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d75fe270480)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737486, encodeId=b6671e37486a7, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=JCO：博来霉素、依托泊苷、顺铂的肺损伤影响有限, objectType=article, longId=63891, objectId=43346389176, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43346389176, replyNumber=0, likeNumber=69, createdTime=2016-09-10, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43346389176, moduleTitle=JCO：博来霉素、依托泊苷、顺铂的肺损伤影响有限, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43346389176)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737480, encodeId=d3f71e3748073, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=招募患者：西达本胺联合紫杉醇和卡铂治疗晚期非小细胞肺癌的Ⅱ期临床试验, objectType=article, longId=56007, objectId=47375600e5b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47375600e5b, replyNumber=0, likeNumber=70, createdTime=2015-11-12, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47375600e5b, moduleTitle=招募患者：西达本胺联合紫杉醇和卡铂治疗晚期非小细胞肺癌的Ⅱ期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47375600e5b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737482, encodeId=36341e3748253, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Sci China Materials：常用抗肿瘤药物顺铂耐药性研究的新发现, objectType=article, longId=57302, objectId=3c895e302cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c895e302cd, replyNumber=0, likeNumber=63, createdTime=2016-08-06, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c895e302cd, moduleTitle=Sci China Materials：常用抗肿瘤药物顺铂耐药性研究的新发现, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c895e302cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737483, encodeId=0aca1e374835f, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=JCO：拉帕替尼联用卡培他滨和奥沙利铂并不延长胃癌患者总生存时间, objectType=article, longId=60099, objectId=b5e3600995e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5e3600995e, replyNumber=0, likeNumber=61, createdTime=2016-02-27, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5e3600995e, moduleTitle=JCO：拉帕替尼联用卡培他滨和奥沙利铂并不延长胃癌患者总生存时间, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5e3600995e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737481, encodeId=749d1e37481c0, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet Oncol：吉非替尼联合铂类化疗用于一线采用吉非替尼治疗的EGFR突变NSCLC进展后治疗并不优于单纯化疗（IMPRESS研究）, objectType=article, longId=56654, objectId=5c1456654c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c1456654c5, replyNumber=0, likeNumber=87, createdTime=2016-07-27, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c1456654c5, moduleTitle=Lancet Oncol：吉非替尼联合铂类化疗用于一线采用吉非替尼治疗的EGFR突变NSCLC进展后治疗并不优于单纯化疗（IMPRESS研究）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c1456654c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737473, encodeId=83d41e37473c3, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Clin Gastroenterol Hepatol：以不典型发热为表现的奥沙利铂高敏反应, objectType=article, longId=45821, objectId=b3824582130, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3824582130, replyNumber=0, likeNumber=69, createdTime=2015-02-25, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3824582130, moduleTitle=Clin Gastroenterol Hepatol：以不典型发热为表现的奥沙利铂高敏反应, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3824582130)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737479, encodeId=26261e3747931, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet：西地尼布联合顺铂和吉西他滨不能改善晚期胆道癌患者, objectType=article, longId=53266, objectId=85715326639, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85715326639, replyNumber=0, likeNumber=67, createdTime=2015-10-21, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85715326639, moduleTitle=Lancet：西地尼布联合顺铂和吉西他滨不能改善晚期胆道癌患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85715326639)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737477, encodeId=05001e3747776, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Ann Oncol：阿瑞匹坦or胃复安+地米预防顺铂致迟发性呕吐疗效相当, objectType=article, longId=47936, objectId=9fe64e9360f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9fe64e9360f, replyNumber=0, likeNumber=68, createdTime=2015-08-30, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9fe64e9360f, moduleTitle=Ann Oncol：阿瑞匹坦or胃复安+地米预防顺铂致迟发性呕吐疗效相当, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fe64e9360f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737475, encodeId=38d31e37475d0, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet Oncology：高风险膀胱癌是否给予铂类辅助化疗？, objectType=article, longId=47448, objectId=2f164e448c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2f164e448c8, replyNumber=0, likeNumber=58, createdTime=2015-06-27, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2f164e448c8, moduleTitle=Lancet Oncology：高风险膀胱癌是否给予铂类辅助化疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f164e448c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737472, encodeId=fc1c1e37472e7, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet Oncology：联合奥沙利铂的辅助治疗可改善III期结肠癌患者存活率, objectType=article, longId=42601, objectId=ca28426010b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca28426010b, replyNumber=0, likeNumber=64, createdTime=2015-07-20, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca28426010b, moduleTitle=Lancet Oncology：联合奥沙利铂的辅助治疗可改善III期结肠癌患者存活率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca28426010b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737476, encodeId=fe071e3747657, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=AJOG：含铂药物可用于妊娠合并宫颈癌的治疗, objectType=article, longId=47893, objectId=b5d24e893fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5d24e893fa, replyNumber=0, likeNumber=70, createdTime=2015-06-02, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5d24e893fa, moduleTitle=AJOG：含铂药物可用于妊娠合并宫颈癌的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5d24e893fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737464, encodeId=13761e374640c, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet Oncol：S-1联合奥沙利铂与卡培他滨联合奥沙利铂一线治疗转移性结直肠癌患者：一项III期临床试验的全新结果, objectType=article, longId=37049, objectId=a8b93e049a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a8b93e049a1, replyNumber=0, likeNumber=85, createdTime=2015-03-11, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a8b93e049a1, moduleTitle=Lancet Oncol：S-1联合奥沙利铂与卡培他滨联合奥沙利铂一线治疗转移性结直肠癌患者：一项III期临床试验的全新结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8b93e049a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737465, encodeId=99881e37465db, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=PNAS：用于增强顺铂化疗功效的纳米粒, objectType=article, longId=37728, objectId=a38c3e7289b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a38c3e7289b, replyNumber=0, likeNumber=68, createdTime=2014-10-27, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a38c3e7289b, moduleTitle=PNAS：用于增强顺铂化疗功效的纳米粒, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a38c3e7289b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737471, encodeId=28381e3747106, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet Oncol：3-4个周期的铂基一线化疗对晚期NSCLCL足够吗？, objectType=article, longId=40924, objectId=ea224092498, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ea224092498, replyNumber=0, likeNumber=79, createdTime=2014-10-20, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ea224092498, moduleTitle=Lancet Oncol：3-4个周期的铂基一线化疗对晚期NSCLCL足够吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ea224092498)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737468, encodeId=c1e61e3746849, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=欧盟批准罗氏安维汀（Avastin）用于铂耐药复发性卵巢癌, objectType=article, longId=38832, objectId=1f85388327a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f85388327a, replyNumber=0, likeNumber=74, createdTime=2015-07-06, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f85388327a, moduleTitle=欧盟批准罗氏安维汀（Avastin）用于铂耐药复发性卵巢癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f85388327a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1737478, encodeId=0a571e3747863, content=<a href='/topic/show?id=292f965e5b5' target=_blank style='color:#2F92EE;'>#铂#</a>, objectTitle=Lancet Oncol：“顺铂联姻化疗”可延长复发转移乳腺癌患者生命, objectType=article, longId=49165, objectId=cd41491651b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cd41491651b, replyNumber=0, likeNumber=68, createdTime=2015-07-06, rootId=0, userName=ms3153534357578991, userId=ca4034296500, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cd41491651b, moduleTitle=Lancet Oncol：“顺铂联姻化疗”可延长复发转移乳腺癌患者生命, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cd41491651b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

铂

2020-05-29

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

ESMO 2016：卡铂+培美曲塞+派姆单抗，可改善NSCLC患者的PFS

2016-12-14

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Support Care Cancer：文拉法辛可减轻紫杉醇-奥沙利铂引发的急性神经毒性

2016-01-18

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

NEJM：Veliparib-卡铂治疗三阴性乳腺癌效果好

2016-07-27

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

JCO：顺铂的耳毒性研究

2017-06-18

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

JCO：博来霉素、依托泊苷、顺铂的肺损伤影响有限

2016-09-10

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

招募患者：西达本胺联合紫杉醇和卡铂治疗晚期非小细胞肺癌的Ⅱ期临床试验

2015-11-12

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Sci China Materials：常用抗肿瘤药物顺铂耐药性研究的新发现

2016-08-06

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

JCO：拉帕替尼联用卡培他滨和奥沙利铂并不延长胃癌患者总生存时间

2016-02-27

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet Oncol：吉非替尼联合铂类化疗用于一线采用吉非替尼治疗的EGFR突变NSCLC进展后治疗并不优于单纯化疗（IMPRESS研究）

2016-07-27

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Clin Gastroenterol Hepatol：以不典型发热为表现的奥沙利铂高敏反应

2015-02-25

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet：西地尼布联合顺铂和吉西他滨不能改善晚期胆道癌患者

2015-10-21

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Ann Oncol：阿瑞匹坦or胃复安+地米预防顺铂致迟发性呕吐疗效相当

2015-08-30

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet Oncology：高风险膀胱癌是否给予铂类辅助化疗？

2015-06-27

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet Oncology：联合奥沙利铂的辅助治疗可改善III期结肠癌患者存活率

2015-07-20

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

AJOG：含铂药物可用于妊娠合并宫颈癌的治疗

2015-06-02

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet Oncol：S-1联合奥沙利铂与卡培他滨联合奥沙利铂一线治疗转移性结直肠癌患者：一项III期临床试验的全新结果

2015-03-11

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

PNAS：用于增强顺铂化疗功效的纳米粒

2014-10-27

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet Oncol：3-4个周期的铂基一线化疗对晚期NSCLCL足够吗？

2014-10-20

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

欧盟批准罗氏安维汀（Avastin）用于铂耐药复发性卵巢癌

2015-07-06

ms3153534357578991 (审核中...)

前往app查看评论内容

#铂#

Lancet Oncol：“顺铂联姻化疗”可延长复发转移乳腺癌患者生命

2015-07-06

科室
- - 订阅+
  - 更多科室
工具
服务